263 results
424B3
BPTH
Bio-Path Holdings Inc
17 Jun 24
Prospectus supplement
8:00am
-K) for the year ended December 31, 2023 have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth
8-K
EX-4.3
BPTH
Bio-Path Holdings Inc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent … reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
8-K
EX-4.2
BPTH
Bio-Path Holdings Inc
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser … , or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
8-K
EX-4.1
jqut4 bp3
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
8-K
EX-10.2
sd4nbkt3
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
8-K
EX-4.4
rfl3uzl6b4l4aa7xkz
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
8-K
EX-10.1
2c1eu1okh8wp0mktty3g
5 Jun 24
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
5:20pm
424B5
7j5okmhs
19 Apr 24
Prospectus supplement for primary offering
3:28pm
8-K
EX-10.1
rf7czv60p iug1h7
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
8-K
EX-4.1
vq9c0iv5 hlyg
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
8-K
EX-4.2
fdijigs
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
424B5
u4nwdy3p kn8mamwvpu
19 Apr 24
Prospectus supplement for primary offering
9:17am
8-K
EX-10.1
wzeywr6izjlc4
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
424B5
szx drsxs
4 Apr 24
Prospectus supplement for primary offering
4:33pm
424B5
c1e2 h7t3d
27 Mar 24
Prospectus supplement for primary offering
8:15am
8-K
EX-10.1
1po04rs5jqp9 ya
26 Mar 24
Entry into a Material Definitive Agreement
8:03am